Join EY during the 2024 healthcare conference week

San Francisco, January 8 – 12 Explore health care, life sciences and private equity opportunities and insights across and between industries.

Ey.ai combines our vast experience with EY technology platforms and leading-edge capabilities.

   

Our recent thought leadership

How CEOs juggle transformation priorities – the art of taking back control

EY CEO survey highlights how CEOs consider AI transformation, ESG and M&A to navigate between immediate profits and future sustainability aspirations. Read more.

How life sciences can make the right deals in a time of change

Life sciences companies are returning to dealmaking amid cost and revenue pressures – how will they find the right deals to secure value? Learn more.

Macro Bites: Beating health care industry challenges

Industry leaders need to look to tech solutions, partnerships and M&A to overcome health care industry challenges.

Top five private equity trends for 2024

Read about the five key trends private equity firms will emphasize in 2024 as they create value

How health care payers are focusing IT spending as costs rise

Download The 2023 EY-Parthenon and KLAS Research Payer Tech Study to discover where payers are making strategic health care IT investments to improve operations.

How will you respond to clinicians sounding the alarm on unsustainable care delivery models?

The EY Global Voices in Health Care Study finds health systems must embrace sustainable care delivery models to address workforce challenges. Learn more.

Pulse of the Industry medical technology report 2023

Our new 2023 report explores medtech industry insights on financing, supply chain and other key topics for medtech company leaders. Learn more.

5 steps life sciences companies can take now to build resiliency

Life sciences executives focus on cost containment and agility in the face of economic and legislative challenges. Learn more.

How to give health consumers the access and experience they value most

The EY Global Consumer Health Survey 2023 findings suggest health executives should focus on access to care, cost and experience factors. Learn more.

Beyond Borders: EY Biotechnology Report 2023

This 33rd edition of our Beyond Borders report sees the US and European biotechnology (biotech) industry seeking a new path forward.


    Contact us
    Find out how EY can support your organization.